Richmond, Jan. 16, 2024 (GLOBE NEWSWIRE) -- According to a research report "Cartilage Regeneration Market" by Treatment Type (Membrane-induced Autologous Chondrocyte Implantation (MACI), Osteochondral Grafting, Osteoarticular Transfer System (OATS), Microfracture surgery, Particulate juvenile articular cartilage allograft transplantation and Other), Indication (Chondral Defects, Osteochondral Defects, Articular Cartilage Defects, Chondral Lesions, Osteochondritis Dissecans Lesions, Osteochondritis Dissecans (OCD), Others), Body Parts (Knee, Hip, Ankle and Foot, elbow, shoulder, Others) and Region - Global Forecast to 2030.
Global Cartilage Regeneration Market Report Scope:
| Report | Details |
| Market size value in 2022 | USD 1.2 Billion |
| Market size value in 2030 | USD 3.0 Billion |
| CAGR (2023-2030) | 12.1% |
| Forecast Period | 2023–2030 |
| Historic Data | 2019 |
| Forecast Units | Value (USD Million/USD Billion) |
| Segments Covered | Treatment Type, Indication, Body Parts and Region |
| Geographies Covered | North America, Europe, Asia Pacific, and RoW |
| |
| |
| Sample of Companies Covered |
|
| |
|
Download the Sample - https://www.marketdigits.com/request/sample/3826
TOC Covers in Depth & Breath on Cartilage Regeneration Market
170 - Market Data Tables
65 - List of Figures
225 – Pages
The report includes Vendor Assessment (Company Profiles, Market Positioning, Strategies, Recent Developments, Capabilities & Product Offerings / Mapping), Technology Assessment (Developments & Economic Impact), Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional FootPrint by MarketDigits.
Market Overview
The cartilage regeneration market occupies an essential role in the healthcare industry, by offering solutions to many indications. The orthopedic diseases and injuries are increasing continuously which increases the delivery in the innovation of treatment of cartilage repair. This factor drives the growth of the cartilage regeneration market. The market segment contains a diverse range of treatment types such as Membrane-induced Autologous Chondrocyte Implantation (MACI), Osteochondral Grafting, Osteoarticular Transfer System (OATS), Microfracture surgery, Particulate juvenile articular cartilage allograft transplantation and, other. This increase is driven by an aging population, an increase in joint conditions including osteoarthritis, and developments in scaffold and cell-based therapies. Although the terms are sometimes used synonymously, cartilage regeneration works to produce fully new cartilage, giving new exciting possibilities, while cartilage repair focuses on promoting the healing of existing tissue. The chance of developing illnesses and needing surgery for cartilage regeneration or repair was higher in the elderly population. It is expected that the increase in aging population will contribute towards growth in the market. Additionally, the market is growing as a result of novel therapies and technology advancements. To promote cartilage regeneration, treatments such as extracellular matrix implants, marrow stimulation drills, allografts, and platelet-rich plasma injections are currently being used.
Major vendors in the global cartilage regeneration market:
- Carmell Corporation
- CarthroniX
- Cytex Therapeutics, Inc.
- Hy2Care
- Lazzaro Medical, Inc.
- Nanochon's Chondrograft
- OCUGEN, INC.
- Orthox
- Regentis Biomaterials
- Synthasome Inc.
- TURN BIOTECHNOLOGIES, INC.
- Vericel
Request for Discount @ https://www.marketdigits.com/request/discount/3826
Increasing Aging Population And Accidents
The increasing aging population and accidents are one of the main factors driving the global Cartilage Regeneration Market. Continuous development in healthcare technology and research increases the growth of the market. Changes in aging can increase the risk of articular cartilage degeneration it includes articular surface fibrillation, size decreases, and decreases in strength and stiffness. This factor drives the market of cartilage regeneration technology. cartilage has less capacity to repair itself because of poor replicative capacity that why regeneration technology is needed. increase accidents and injuries while sports also cause cartilage injuries which need the treatment of cartilage regeneration. The market for cartilage regeneration is being driven by the growing aging population, which is facing a decrease in its ability to regenerate cartilage, combined with an increase in injuries from accidents. The combination of populations drives the industry toward cutting-edge therapies like stem cell treatments and tissue engineering by increasing demand for efficient cartilage repair options, especially minimally invasive procedures with reduced recovery times.
Market Dynamics
Drivers:
- Increase in joint pain conditions like oisteoarthritis
- Increasing aging population and accidents
- Funding And Investment In Research Is Increasing
Opportunities:
- Increasing Demand For Scaffold And Cell-Based Therapies
- Demand For New Technological Developments
Increasing Demand for Scaffold And Cell-Based Therapies
Increasing Demand For Scaffold And Cell-Based Therapies plays an essential role in the growth of the cartilage regeneration market. Continuous development in advanced technology contributes to novel innovation and less time-consuming treatments. It also decreases the cost and is biodegradable which raises the demand. The growing need for scaffold and cell-based therapeutics is driving the amazing potential in the field of cartilage regeneration. The increasing occurrence of musculoskeletal problems shows the urgent need for novel approaches that can adequately address cartilage degeneration. Scaffold-based methods are generating interest because of their potential to improve tissue regeneration. They work by using biocompatible materials to form supporting scaffolds for cell growth. At the same time, cell-based treatments, which make use of the chondrocytes or stem cells' capacity for regeneration, present promising possibilities for cartilage function regeneration.
The need for better treatment outcomes, an aging population, and sports-related injuries are the main factors driving the rising demand for these innovative regenerative technologies. Research institutes and pharmaceutical businesses are among the market participants in cartilage regeneration that have the potential to profit from this development.
North America Dominates the Market for Cartilage Regeneration Market
North America stands out as the dominating region in the global cartilage regeneration market, with the United States leading in consumption and market share. The region's dominance is due to Continuous development in advanced technology. The government is making significant investments in technology and therapies for cartilage repair and regeneration, and an increasing number of healthcare professionals and consumers are becoming aware of these newly established treatment techniques and technologies. These factors are contributing to the speed of the market growth in North America. The growing number of elderly and obese people in North America, together with an increasing number of bone and joint problems, are the main factors driving the expansion of the cartilage repair and regeneration market.
Asia-Pacific is emerging as a key player with substantial growth potential in the Cartilage Regeneration Market. Governments and private investors in Asia are becoming more interested in research and technology translation, as the technology has huge potential for driving a sustainable bio-based economy. The following perspective examines the most recent advancements in the cartilage regeneration market primarily using technologies and their use in the treatment of indication.
The Membrane-Induced Autologous Chondrocyte Implantation (MACI) Segments Is Anticipated To Hold The Largest Market Share During The Forecast Period
In the global Cartilage Regeneration Market, the treatment segment comprises various categories such as Membrane-Induced Autologous Chondrocyte Implantation (MACI), Osteochondral Grafting, Osteoarticular Transfer System (OATS), Microfracture Surgery, and others. This Membrane-Induced Autologous Chondrocyte Implantation (MACI) segment's dominance in synthetic biology can help its role in medical treatments, pharmaceutical developments, and research. Through a surgical process called MACI, damaged knee cartilage is repaired using the body's cartilage-forming cells. Chondrocytes, or cartilage-forming cells, are obtained via biopsy and then allowed to proliferate in a lab before being surgically implanted into the injured area. Specialists gather cells using a small-punch biopsy technique as compared to a more invasive arthroscopic procedure. This method decreases recovery and cost by combining two procedures into one. It is encouraged that future research concentrate on creating scaffolds that are more biocompatible and biodegradable in order to ensure their compatibility with the physiological environment. Another significant issue for research is how to effectively increases growth factors and other bioactive compounds, as this could significantly enhance the therapeutic efficacy of these scaffolds.
Inquire Before Buying: https://www.marketdigits.com/request/enquiry-before-buying/3826
Browse Similar Reports:
Joint Replacement Market 2030 By Type, Distribution Channel, End-user and Region - Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional Footprints by MarketDigits
Bone Densitometers Market 2030 By Type, Distribution Channel, End-user and Region - Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional Footprints by MarketDigits
Bone Marrow Transplant Market 2030 By Type, Distribution Channel, End-user and Region - Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional Footprints by MarketDigits
About MarketDigits:
MarketDigits is one of the leading business research and consulting companies that helps clients to tap new and emerging opportunities and revenue areas, thereby assisting them in operational and strategic decision-making. We at MarketDigits believe that a market is a small place and an interface between the supplier and the consumer, thus our focus remains mainly on business research that includes the entire value chain and not only the markets.
We offer services that are most relevant and beneficial to the users, which help businesses to sustain themselves in this competitive market. Our detailed and in-depth analysis of the markets catering to strategic, tactical, and operational data analysis & reporting needs of various industries utilize advanced technology so that our clients get better insights into the markets and identify lucrative opportunities and areas of incremental revenues.
Contact Us:
MarketDigits
1248 CarMia Way Richmond,
VA 23235,
United States.
USA: +1 847 450 0808
Email: sales@marketdigits.com
Web: https://www.marketdigits.com
Follow Us on: | Twitter | LinkedIn |
